PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Virology Laboratory, Butantan Institute, São Paulo, Brazil.\', \'Viral Biotechnology Laboratory, Butantan Institute, São Paulo, Brazil.\', \'Multipurpose Laboratory, Butantan Institute, São Paulo, Brazil.\', \'Microbiology Department, Biomedical Science Institute, University of São Paulo, São Paulo, Brazil.\', \'Institute for Energy and Nuclear Research, São Paulo, Brazil.\', \'Quality Control, Butantan Institute, São Paulo, Brazil.\', \'Direction, Butantan Institute, São Paulo, Brazil.\', \'Bioindustrial Center, Butantan Institute, São Paulo, Brazil.\', \'Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil.\', \'Viral Vaccines Pilot Laboratory, Butantan Institute, São Paulo, Brazil.\', \'Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil.\', \'Center of Excellence in New Target Discovery (CENTD), Special Laboratory, São Paulo, Brazil.\', \'Bioindustrial Center, Butantan Institute, São Paulo, Brazil. fan.hui@butantan.gov.br.\', \'Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil. denise.tambourgi@butantan.gov.br.\', \'Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil. ana.chudzinski@butantan.gov.br.\', \'Center of Excellence in New Target Discovery (CENTD), Special Laboratory, São Paulo, Brazil. ana.chudzinski@butantan.gov.br.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-07793-1
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35273234
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-SARS-CoV-2 equine F (Ab\')2 immunoglobulin as a possible therapy for COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35273234>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35273234>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all